- FDA Approves New Drug for Treatment|Resistant Forms of ...🔍
- FDA approves tuberculosis drug that works on hard|to|treat cases🔍
- Not|for|profit to launch antibiotic against drug|resistant tuberculosis🔍
- After 40 Years a New TB Drug is Approved🔍
- Realizing our “Triple|A Mandate”🔍
- FDA advisory panel recommends approval of TB Alliance's ...🔍
- FDA approves new cure for deadly strain of drug|resistant TB🔍
- Statement from Treatment Action Group on U.S. FDA Approval of ...🔍
U.S. FDA approves TB Alliance's treatment for drug|resistant ...
FDA Approves New Drug for Treatment-Resistant Forms of ...
The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a ...
FDA approves tuberculosis drug that works on hard-to-treat cases
The TB Alliance said pretomanid should be available in the United States by the end of the year. The group is also seeking approval from ...
Not-for-profit to launch antibiotic against drug-resistant tuberculosis
Pretomanid is the third new drug approved by the FDA in over 40 years, and a victory for the not-for-profit TB Alliance.
After 40 Years a New TB Drug is Approved | Taconic Biosciences
Nonprofit Wins FDA Approval for Tuberculosis Drug · About TB · The TB Alliance · FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis · Mouse ...
Realizing our “Triple-A Mandate” - TB Alliance
Four years ago, TB Alliance secured the first regulatory approval from the United States Food and Drug Administration (US FDA) for the new ...
FDA advisory panel recommends approval of TB Alliance's ... - Reuters
Independent experts of an FDA advisory panel voted in favor of the not-for-profit TB Alliance's treatment for drug resistant tuberculosis, ...
FDA approves new cure for deadly strain of drug-resistant TB - Axios
This new treatment lowers that dose to 5 pills/day over 6 months for most patients. A spokesperson for the nonprofit TB Alliance, which ...
Statement from Treatment Action Group on U.S. FDA Approval of ...
“Many people with extensively or pre-extensively drug-resistant TB would welcome a three-drug, all-oral, six-month regimen with a high cure rates, and therefore ...
FDA Approves New Pill for Drug-Resistant TB - WSJ
Pretomanid is only the third new TB drug to be approved by the FDA in more than 40 years, according to the TB Alliance. The group's aim in ...
New Drug Could Be Game Changer For Drug-Resistant TB. But A ...
People with drug-resistant tuberculosis take many pills over a long period of time. Cure rate is low. The FDA has now approved a drug with ...
First New Tuberculosis Drug Approved in 50 Years - The Scientist
The US Food and Drug Administration green lights a therapy for an extreme form of multidrug resistant TB. ... A treatment regimen for extensively ...
New drug to fight deadliest form of TB must be made affordable
US FDA approves pretomanid, a potential lifesaver for people with drug-resistant TB. ... TB Alliance's mandate to deliver affordable treatment ...
X-ray Experiments Contribute to FDA-Approved Anti-Tuberculosis ...
The U.S. Food and Drug Administration has approved a new antibiotic that, in combination with two existing antibiotics, can tackle one of ...
Tuberculosis: experts question evidence and safety data used to ...
US Food and Drug Administration. FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs. · Drug-resistant TB ...
New Drug Approved for Treatment of Extensively Drug-Resistant ...
Dr. Doris Rouse discusses the FDA's approval of pretomanid, a groundbreaking treatment for extensively drug-resistant tuberculosis (XTB).
DNDi congratulates the TB Alliance for the FDA approval of a ...
... TB Alliance and its partners on receiving approval from the U.S. FDA for pretomanid for the treatment of highly drug-resistant forms of TB.
212862Orig1s000 - accessdata.fda.gov
The IND submitter, TB Alliance, is a small, not-for-profit public-private partnership aimed at finding treatment for drug-resistant tuberculosis ...
FDA advisory panel recommends approval of TB Alliance's TB ...
Independent experts of a US Food and Drug Administration (FDA) advisory panel voted in favor of TB Alliance's treatment for multi-drug resistant ...
TB Drug Development (TB Alliance) - Global Health Progress
To date, 15 countries or regulatory bodies have approved pretomanid as part of the BPaL regimen for treating patients with highly drug-resistant forms of TB, ...
Search Orphan Drug Designations and Approvals - FDA
Pretomanid tablet is indicated, as part of a combination regimen with bedaquiline and linezolid for the treatment of adults with pulmonary extensively drug ...